According to a recent LinkedIn post from Elanco, the company is emphasizing growing global demand for animal protein and the role of livestock health in meeting that demand. The post cites a doubling of meat sales over the last five years and notes that new dietary guidelines are prioritizing protein intake, while consumer products like cottage cheese continue to see strong demand.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights that roughly 20% of livestock productivity is currently lost to death and disease, suggesting a substantial efficiency gap in global protein production. It further notes that closing this gap could theoretically provide enough additional animal protein to feed another 1.5 to 2 billion people, underscoring the scale of the addressable market for animal health solutions.
As shared in the post, Elanco’s CEO Jeff Simmons appeared on Bloomberg’s “The Close” to discuss how innovation in animal health could make meat, milk, and eggs more affordable and accessible. For investors, this focus on innovation positions Elanco as a potential beneficiary of long-term structural trends in protein consumption and food security, with improved livestock health potentially driving higher demand for the company’s products.
The content suggests that Elanco is framing animal health not only as a productivity lever for producers, but also as a response to inflationary pressures on food and rising consumer demand for protein. If the company can convert these themes into scalable technologies and services, it could strengthen its competitive position in the animal health industry and support revenue growth tied to global protein markets.